Generic drug makerLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field. in IsraelLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field.. FDA records under its name, each linked to the record.
As of Nov 13, 2026, FDA's public records list Dexcel Pharma and its 1 subsidiaries with 15 drug applications, 1 drug recall and 1 OPDP letter. The most recent is an OPDP letter dated Feb 3, 2025: Untitled letter: HEMADY.
Drug approvals, 510(k) clearances, recalls and letters, 2017 to 2026 to date, Dexcel Pharma and its 1 subsidiaries
A hatched bar is a year that is not over, so its count covers only part of the year.
| Date | Record | Source |
|---|---|---|
| Feb 3, 2025 | Untitled letter: HEMADYOffice of Prescription Drug Promotion | OPDP letters |
Spellings are joined only when they reduce to the same name, or a reviewed source names the same company. Sharing an FDA establishment number (FEI) is not enough: contract sites make products for many firms. Facts marked AI were labelled by a language model from the firm's FDA names; everything else comes from FDA or Wikidata. How this page is built
